Cathay Health
Venture capitalSan Francisco · Seed–Late Stage · 5 people tracked
Also known as CATHAY CAPITAL NA, LLC
Find your way into Cathay Health
539 people in our graph share verified history with the Cathay Health team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Cathay Health invests in companies operating at the convergence of life sciences, healthcare, and technology, targeting positive impact on human health. Its focus areas include life science tools, diagnostics, clinical trial innovation, new care models, novel devices and materials, and enabling technologies for advanced therapies. The firm both invests in and operates at this convergence, backing businesses spanning surgical robotics, biomaterials, gene and cell therapy manufacturing, and health tech venture creation.
Source: firm website, verified Sep 15, 2026.
Team · 5 people
from curated & public directories
What they invest in
from 4 of 6 portfolio companiesBiotech ×3Medical Devices ×3Healthtech ×2Deep Tech ×1New Materials ×1Robotics ×1
HQs:United States×2Germany×1France×1
Investments · 6 tracked
founders shown can be your intro pathBy year:2023 · 12021 · 12 dated
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.
BiotechHealthtechMedical DevicesMunich, DE
PartnerEric De La Fortelle· solo GP
Co-investorsMonograph Capital PartnersDigitalis Ventures
PartnerEric De La Fortelle· solo GP
Co-investorsKurma PartnersCAP HORN VC
PartnerEric De La Fortelle· solo GP
BiotechBoston, US
Nagesh Mahanthappa, Ph.D.(Director)Luba Greenwood(Director)in
BoardAmir Nashat, Ph.D.(Treasurer and Secretary)Susan Langer(President)Thomas J. Cahill(Director)
Co-investors5AM VenturesNewpath Partners
Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.
HealthtechMedical DevicesRoboticsParis, FR
Brice Gayet(Founder)inAnne Osdoit(Chief Executive Officer)inEric Ermenault(Chief Commercial Officer)inAnne Renevot(Chief Financial Officer)inViola Fleig(Chief Operations Officer)inDavid Noonan(Chief Technology Officer)in
PartnerEric De La Fortelle· solo GP
Co-investorsSofinnova PartnersNVIDIAJohnson & Johnson Innovation – JJDCNVentures
TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.
BiotechDeep TechMedical DevicesNew Materials
Christophe Bancel(Co-founder & CEO)inMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in
PartnerEric De La Fortelle· solo GP
Co-investorsKaristaSofinnova PartnersEuropean Investment Bank
Portfolio news
latest coverage across their companiesTissium · finance.yahoo.com · Jun 25, 2026
Kojin Therapeutics · ellty.com · Dec 18, 2025
Frequently asked questions
- How many investments has Cathay Health made?
- Cathay Health has 6 tracked investments.
- What stage does Cathay Health invest at?
- Cathay Health invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Cathay Health focus on?
- Cathay Health focuses on Advanced Manufacturing, Biotech, Consumer, Crypto & Web3, Deep Tech, Digital Health, Healthtech, Medical Devices, New Materials, Robotics.
- Where is Cathay Health located?
- Cathay Health is headquartered in San Francisco, US.
- Who does Cathay Health co-invest with?
- Cathay Health most often shares deals with Sofinnova Partners, Karista, Kurma Partners, among 4 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Industrial Technology Investment Corporation is the venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), backing startups across multiple stages and sectors while providing access to ITRI's R&D resources.
This page is the analysis and research library of the Business Development Bank of Canada (BDC), publishing studies, surveys and reports on issues affecting small and medium-sized businesses in Canada.
AddVentures is the corporate venture capital arm of SCG, one of the largest industrial conglomerates in Southeast Asia. It engages with tech startups worldwide through partnerships and investments, leveraging SCG's network and resources across the region.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.